Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Finished Goods (2016 - 2020)

Historic Finished Goods for Trinity Biotech (TRIB) over the last 5 years, with Q4 2020 value amounting to $12.9 million.

  • Trinity Biotech's Finished Goods rose 366.14% to $12.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $12.9 million, marking a year-over-year increase of 366.14%. This contributed to the annual value of $12.9 million for FY2020, which is 366.14% up from last year.
  • According to the latest figures from Q4 2020, Trinity Biotech's Finished Goods is $12.9 million, which was up 366.14% from $12.4 million recorded in Q4 2019.
  • Trinity Biotech's 5-year Finished Goods high stood at $16.1 million for Q4 2016, and its period low was $11.6 million during Q4 2018.
  • Over the past 5 years, Trinity Biotech's median Finished Goods value was $12.9 million (recorded in 2020), while the average stood at $13.6 million.
  • Per our database at Business Quant, Trinity Biotech's Finished Goods crashed by 2404.1% in 2018 and then soared by 746.28% in 2019.
  • Trinity Biotech's Finished Goods (Quarter) stood at $16.1 million in 2016, then decreased by 5.59% to $15.2 million in 2017, then fell by 24.04% to $11.6 million in 2018, then rose by 7.46% to $12.4 million in 2019, then rose by 3.66% to $12.9 million in 2020.
  • Its Finished Goods stands at $12.9 million for Q4 2020, versus $12.4 million for Q4 2019 and $11.6 million for Q4 2018.